Cancer therapy is a newer frontier for exploring ashwagandha as a potential therapy. Preclinical studies on withaferin A (an isolated constituent of ashwagandha) indicate it may inhibit or control cancer metastasis in animal and cell models.[1][2][3][4] In humans undergoing chemotherapy for breast cancer, ashwagandha as a whole-herb supplement has demonstrated an increase in well-being and physical/emotional function, and a reduction in fatigue, insomnia, and pain.[5]
What else has ashwagandha been studied for?
Written by:
Fact-checked
by:
•Last Updated: May 16, 2025
Ashwagandha has been studied as a potential cancer therapy, and preclinical studies suggest that withaferin A may inhibit cancer metastasis. Additionally, in humans who are undergoing chemotherapy for breast cancer, ashwagandha has shown benefits in well-being, physical and emotional function, and reductions in fatigue, insomnia, and pain.